Amoksiklav

Medicinal product

(Invented) name

Amoksiklav

Active substance (s)

Amoksicilinas/Klavulano rūgštis

Strength

875 mg/125 mg

Pharmaceutical form

disperguojamosios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01CR02, Amoxicillin and beta-lactamase inhibitor

Marketing authorisation holder

Sandoz d.d., Slovėnija

Date of authorisation

2007-01-25

Date of renewal

2012-05-21

Documents

0640 Pakuotės lapelis 875_125 disperg 2023 12 18t.docx

0640 Amoksiklav 875_125mg disperg PCS PL 2023 12 18t.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Amoksicilinas	875 mg
Klavulano rūgštis	125 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
17731	21522	1021522	lizdinė plokštelė	N10		Receptinis	LT/1/95/0640/003	Netiekiama	-	-	No	-	-
17732	4686	1004686	lizdinė plokštelė	N14		Receptinis	LT/1/95/0640/004	Netiekiama	2024-10-18	-	No	-	-	Download

Stadijos

Data	Stadija
2012-05-21	Perregistruotas
2007-01-25	Registruotas